chrisvoncsefalvay/vaers-outcomes huggingface dataset:
February 25, 2021 approximately 9:30 am:  Approximately 5 minutes after receiving vaccine had a strong medicine taste in throat.  Lasted 45 minutes - 1 hour.  Approximately 9:55 am slight feeling of throat closing, which lasted about 45 minutes.  Approximately 10:00 am headache, which lasted until approximately 4:00 pm, February 26, 2021.  Arm soreness evening of February 25, 2021 lasted approximately 2 weeks.          February 26, 2021 approximately 6:00 am diarrhea, headache, chills, legs aching, and fatigue, which lasted until until approximately 4:00 pm.
Swollen left armpit lymph node; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 33-year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Oct2021 11:30 (Lot number: 30135BA) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Seasonal allergies" (ongoing); "Allergies/ Mostly pollen allergies" (ongoing), notes: Allergies/ Mostly pollen allergies. Concomitant medication(s) included: ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for seasonal allergy, start date: 2000 (ongoing); FLONASE [FLUTICASONE PROPIONATE] taken for seasonal allergy, start date: 2000 (ongoing); PRILOSEC [OMEPRAZOLE MAGNESIUM]; VITAMIN D 2000; L-5HPT; YAZ. Past drug history included: Pistachios, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose 2; Batch/Lot No: ER8732; Location of injection: Arm Right; Vaccine Administration Time: 11:00 AM; Route of administration: Intramuscular), administration date: 07Apr2021, when the patient was 33 years old, for Covid-19 Immunization; Bnt162b2 (Dose 1; Batch/Lot No: EN6202; Location of injection: Arm Right; Vaccine Administration Time: 11:30 AM; Route of administration: Intramuscular), administration date: 09Mar2021, when the patient was 33 years old, for Covid-19 Immunization; Flu vaccine (Dose 1; Batch/Lot number: Unknown; Location of injection: Left arm; Vaccine Administration Time: 11:30 AM; Route of administration: Muscular), administration date: 29Sep2021, when the patient was 33 years old, for Immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 03Oct2021 10:00, outcome "recovered" (2021), described as "Swollen left armpit lymph node". Therapeutic measures were not taken as a result of lymphadenopathy. Additional information: Relevant Tests: None. Vaccination facility type: Pharmacy or drug store. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Device Date: 04Oct2021. No follow-up attempts are possible. No further information is expected.
POST VACCINE, DEVELOPED TIGHTNESS IN THROAT, DENIED SOB. BROUGHT TO OBS, RELIEVED AFTER 15 MINS, DID DEVELOP SMALL RED RASH ON LEFT HAND, IMPROVED, INSTRUCTED TO SEEK FURTHER EVAL FOR RECURRING/WORSENING/PERSISTING S/S. ESCORTED TO EXIT WITH NO ISSUES AT 1205. 1135 INITIAL BP 164/92 HR 68 SATS 94% RA 1138 BP 155/88 HR 71 SATS 94% RA 1200 BP 147/86 HR 65 SATS 98%
fever; I have dystonia (OMD)/ my symptoms have been aggravated the last few days; I have dystonia (OMD)/ my symptoms have been aggravated the last few days; This is a spontaneous report from a contactable consumer (patient). A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in arm left on 17Feb2021 16:45 (batch/lot number: EN 6200) as a single dose for COVID-19 immunisation. Medical history included dystonia (OMD), multi nodular goiter, fatty liver, and uterine fibroids. The patient was not pregnant at the time of vaccination. Concomitant medications included omeprazole, colecalciferol (VITAMIN D), and tonic lemonade with thc; taken for unspecified indications, start and stop dates were not reported. The patient previously took amoxicillin clavulanate and experienced allergies. On 27Feb2021 16:00, the patient has just developed a fever and she really doesn't get fevers. She was normally low at 96.7 and today she was 98.7. She has dystonia (OMD) and her support group was reporting Covid vaccines were making dystonia symptoms worse. Her symptoms have been aggravated the last few days. She had no dystonia reaction until the last 2 days and symptoms might not have anything to do with the vaccine. She was just reporting this because her support group was saying they were worse since the vaccine. She was concerned she has a fever since she never gets them. She hasn't been out of the house since the vaccination. Facility type for the vaccine was a school or student health clinic. No other vaccine in four weeks. No Covid prior to vaccination and was not Covid tested post vaccination. There was no treatment received for the events. The outcome of the events was unknown.
Patient reports site redness and itching 2 days after injection given; patient denies any fever, no pain, just itching at site.
Patient went to urgant care on 6/16/19 presenting with a raised rash on the right side of her chest. She was prescribed a course of doxycyline for 7 days. The rash is still present as of 6/22/19, but the patient has noticed improvement, stating the symptoms were worst on 6/16/19.
post injection moderate increase in tinnitus noted about 5-7 days later and currently unresolved; increase in hearing difficulty due to tinnitus ongoing; This is a spontaneous report from a contactable nurse (patient herself). A 51-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL1284) via unknown route of administration on 31Dec2020 08:30 AM at single dose in right arm for COVID-19 immunization at Hospital. Medical history included hearing loss and ongoing tinnitus. Allergies to medications, food, or other products included penicillin, sulfa, levoquin. The patient was not pregnant at time of vaccination. No other vaccines have been administered within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant other medications the patient received within 2 weeks of vaccination included multivitamin. It was reported as post injection moderate increase in tinnitus noted about 5-7 days later in Jan2021 and currently unresolved. Also increase in hearing difficulty due to tinnitus ongoing in Jan2021. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for the adverse events. The outcome of events was not recovered.  No follow-up attempts are possible. No further information is expected.
minor lip swelling, hives and itching  20 minutes after 1st shot; minor lip swelling and worse hives and itching, worse than 1st vaccine,  which have continued 10 days later.
Patient felt very dizzy couple minutes after receiving the Pfizer Covid Vaccine. he felt tire, could not hear well, and was very pale. His blood pressure was 80/47, pulse was 49. 911 was called and his blood pressure went up slowly to 90s/70s.
Hives on neck and face, diarrhea, stomach cramps, nausea, loss of appetite, headache, injection site pain, injection site itching
From initial information received on 05/14/2004 from a healthcare professional regarding an adverse event occurring in the USA, it was reported that a 47 year old female patient received a TD ADS Adult vaccination, lot number U1024AA, administered intramuscularly in the left deltoid on 05/11/2004.  The next day, on 05/12/2004, the patient experienced a local red area at the injection site.  She was seen in the office on 05/14/2004 with a 9.5 x 8 mm area of redness and a 7.5 x 5cm area of induration.  The area was also warm and painful to the touch.  It is unknown if the patient recovered from these events.  From additional information received on 09/22/2004 from a healthcare professional, it was reported that a nurse spoke with the patient on 09/15/2004.  At that time, the patient still had a dime-sized knot at the injections site, but stated that it was slowly getting smaller.  It was noted that there was no pain at the site.  Outcome for the rest of the reported events was not provided.
little bit more forgetful; little tenderness at the side; This is a spontaneous report received from contactable reporter(s) (Other HCP and Physician).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MEMORY IMPAIRMENT (non-serious), outcome "unknown", described as "little bit more forgetful"; TENDERNESS (non-serious), outcome "unknown", described as "little tenderness at the side".  Additional information: doctor said his father had a little, just little tenderness at the side. He think he was, might've been a little bit more forgetful that day. But that's his usual.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 5-6 hours after injection, experienced flu-like muscle/body aches, fatigue, slight fever for 36 hours. Some improvement each day (less aches and less fatigue). After 4 days, feeling back to normal, except for a little less energy. Appears I had the reaction as stated in the Vaccine Information Statement, part 4: Reaction Risks.
Blistering vesicular rash on both hands 2 days after first dose of SHINGRIX vaccine.
pediatric dose instead of an adult dose; Adult use of child product; This case was reported by a nurse via call center representative and described the occurrence of underdose in a 39-year-old female patient who received HBV (Engerix B pediatric) (batch number K329E, expiry date 24th April 2023) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 12th October 2021, the patient received Engerix B pediatric .5 ml and Engerix B Pre-Filled Syringe Device. On 12th October 2021, unknown after receiving Engerix B pediatric and Engerix B Pre-Filled Syringe Device, the patient experienced underdose and adult use of a child product. On an unknown date, the outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The nurse reported that the adult patient received a pediatric dose of Engerix-b (0.5 ml) instead of an adult dose (1 ml), which led to underdose and adult use of a child product. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.
Severe serum sickness reaction. Pulmonary edema, hypertension, asthma. Hemolytic anemia, rash prolonged fatigue (months).
HYPOTENSION  2/23/2022 & 4/20/2022 - - RECURRENCE OF SAME SYMPTOMS
This case was reported by a physician via a sales representative and described the occurrence of adverse event in a subject of unspecified age and gender who was vaccinated with FLUARIX (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of FLUARIX (unknown). At an unspecified time after vaccination with FLUARIX, the subject experienced an unspecified adverse event described as a sensitivity reaction. At the time of reporting the outcome of the event was unspecified. The sales representative stated that she was at a large convention on 30 September 2008 and was approached by a physician that reported his hospital had suspended administration of FLUARIX due to 6 subjects developing adverse events after receiving the FLUARIX vaccination. No details of the report are available and the sales representative heard the report third hand. Linked cases include: A0753365A, A0753367A, A0753368A, A0753370A, A0753371A.
On 11/25/08 at 2017, infant with increasing number & severity of apneic episodes. On 11/26/08, apnea not responsive to vigorous stim, req'd resuscitation with PPV at 1215, 2005, 2125, & 11/27 at 0545. Was made NPO, septic work-up & antibiotics begun.  1/6/09 MR received for DOS 9/20-12/24/2008. Infant born 9/2008 at 26 weeks gestation with IUGR, twin c-sec delivery. Immediately to NICU. Received 1st vax 11/24/08 which increased episodes of apnea, O2 desaturations and bradycardia requiring PEEP. By 12/22/08 on RA with occ O2 for feeds.  Improved with theophylline by 12/24/08.
7 m/o male with fever to 40c resulting in hospital admission, sepsis workup and observation for 48hrs
Noticed bright redness and soreness around TDAP injection site. Redness, soreness, and swelling increased throughout the next 36 hours, and temperature became elevated. Dr. diagnosed bacterial infection and prescribed Z-pac. Dr. noted that many patients are having adverse reaction to TDAP.
Four hours after vaccine started feeling under arm pain, swelling and tenderness in the same arm  as the vaccination. Lasted about 2 days then subsided. Then  about 4 months started experiencing under arm pain again and tenderness again. Went to doctor and was advised to get an Ultrasound. My doctor wanted me to have my yearly Mammogram, so it was decided that I would have the area observed at the same appointment. Was told that Lymph nodes were slightly swollen and to come back in 3 months for further testing. Pain has subsided since then.
dry throat; Dizziness; Tingling of the tongue, roof of the mouth, around the lips, and on the face; Tingling of the tongue, roof of the mouth, around the lips, and on the face; Tingling of the tongue, roof of the mouth, around the lips, and on the face; Tingling of the tongue, roof of the mouth, around the lips, and on the face; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 60 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious) with onset 25Mar2021, outcome "unknown", described as "Dizziness"; PARAESTHESIA ORAL (non-serious), PARAESTHESIA ORAL (non-serious), PARAESTHESIA ORAL (non-serious), PARAESTHESIA (non-serious) all with onset 25Mar2021, outcome "unknown" and all described as "Tingling of the tongue, roof of the mouth, around the lips, and on the face"; DRY THROAT (non-serious), outcome "unknown", described as "dry throat".  Additional Information: Caller mentioned that the young gentleman next to her experienced similar symptoms right after getting the Covid 19 Vaccine on 25 Mar 2021. They both had dizziness and tingling of the tongue, roof of the mouth, around the lips, and on the face. She also said that he had a dry throat. Up on Follow up on PRD/SRD 07Apr2021 A contactable 60 year old female reporter (patient) reported for herself that: Caller stated she already reported AE and was transferred. Caller is a consumer, (Withheld) "had first dose of the Pfizer COVID vaccine, after the first got really dizzy and had tingling around my mouth and tongue, around mouth and the roof of the mouth, especially the face and lips. It did go away, but She worried about a possibly worse reaction with second dose. There was also a young man that had same reaction. Responded per documents attached and referred back to her HCP for medical advice. Responded per Fact Sheet for Recipients and Caregivers, section: WHAT ARE THE RISKS OF THE PFIZER-BIONTECH COVID-19 VACCINE? As noted in the Fact Sheet for Recipients, you should not get the Pfizer-BioNTech COVID-19 Vaccine if you had a severe allergic reaction after a previous dose of the vaccine or if you had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. They refer her to speak to her healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Your healthcare provider knows your health situation and has access to information that can better help inform this decision.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
History of atopic dermatitis rash primarily winter months  4/14/21 Pfizer vaccine, 1 week after developed rash with itchy rash with red, raised itchy lesions legs, buttocks, back, arms, abdomen, persisted about 10 days; tried loratadine didn't seem to help much. No shortness of breath, cough, wheeze, tongue or throat swelling, lightheadedness, dizziness or emesis reported.  No other reactions to vaccinations or injectable medications   IMPRESSION/PLAN: Delayed urticarial rash with Pfizer vaccination, resolved in about 10 days. With the delayed nature of the reaction would not be concerned about IgE mediated reaction, ok to receive second dose Pfizer vaccine with 30 minute observation after.    Unclear if pt had a reaction w/ 2nd dose 5/13/21.
Pain left arm at site of infection,  tingling and numbing of my last 2 fingers on left hand
chills, fatigue, fever, rhinorrhea, sore throat, myalgias, weakness, headaches
Multiple gradually progressive apthous ulcers in my oropharynx that developed over the course of a week and have been painful and persistent for 6 days and counting. Painful to talk and painful in certain positions or if food touches them.
I had an odd "mole-like" large spot suddenly appear on my left forearm/another similar looking spot has appeared about 3 inches away from the first one; Today I was very lethargic most of the day; chills, achiness, headache, and a fever of 100.6 deg F; chills, achiness, headache, and a fever of 100.6 deg F; chills, achiness, headache, and a fever of 100.6 deg F; chills, achiness, headache, and a fever of 100.6 deg F; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), at an unknown route at right arm on 18Feb2021 at 11:00, (lot number=EN5318) (age at vaccination 58-year-old) as dose 2, single for COVID-19 immunization in the workplace clinic. The patient had known allergies zithromax. The patient medical history included hypertension from an unknown date and unknown if ongoing. The patient had taken 4 hypertension medications in 2 weeks. The patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) at right arm on 28Jan2021 at 02:30 PM (lot number: EN5318) as dose 1, single for COVID-19 immunisation. The patient concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient was very lethargic most of the day and had chills, achiness, headache and a fever of 100.6 deg F on 19Feb2021 at 6:30 AM and had an odd "mole-like" large spot suddenly appear on my left forearm/another similar looking spot has appeared about 3 inches away from the first one on 21Feb2021. The patient did not received treatment for the events. The event odd "mole-like" large spot suddenly appear on my left forearm/another similar looking spot has appeared about 3 inches away from the first one was not recovered and the outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Symptoms: Erythema Multiform. Treatment: Cephalexin 500 mg QID
I had fever, myalgia and arthralgia. Stiffness, inflammation on my right knee. I could not move from my bed for one week. I was using cane for two months. Right now, I am using a knee pad, and more ambulatory.
Headache, nausea, vomiting, chills, IV fluids, ZOFRAN IV.
Headache, Muscle pain, Chills, Nausea, abdominal pain, Joint pain, diarrhea, leg pain, extreme fatigue, racing heart
1/22/22  62 yr/o female who presents with complaint of shortness of air, chest wall and rib pain for the past week.  She was diagnosed with COVID one week ago.  She has PMH that includes asthma and PA.  Shortness of breath has worsened during this time. 1/22/22 History of Present Illness: Patient is a 62 yr/o with PMH significant for asthma who was tested positive for COVID-19 almost a week ago although the patient did receive the 2 doses of the vaccine, she was feeling overall okay however for the last 3 days her shortness of breath been getting worse patient did not require any oxygen supplement when she was tested positive neither when she came in yesterday to the ED her chest x-ray was clear however patient on exam clearly has some wheezing.  She does not use nebulizer or inhalers at home Review of Systems: General: Denies any weight change, fatigue, weakness, fever, chills, or night sweats. Denies any consumption of raw or undercooked meats or foods, change in water source, travel, or missed routine medications. Skin: Denies any skin, hair, or nail changes. Denies any rashes or sores Neuro: denies headache, dizziness, syncope, falls or trauma, changes in vision, hearing, or taste, focal weakness, numbness, paresthesias, fainting or seizures   Sinus: Denies any sinus pressure, rhinorrhea, epistaxis,  Cardio: Denies chest pain, or palpations, dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea, or edema Pulmonary: Positive for shortness of breath GI: Denies change in appetite, denies nausea, vomiting, hematemesis, diarrhea, constipation, hematochezia, abdominal pain GU: Denies frequency, hesitancy, urgency, polyuria, dysuria, hematuria, nocturia, incontinence   Endocrine: Denies heat or cold intolerances, polyphagia, polydipsia, polyuria Psyc: Denies anxiety or depression 1/23/22 Brief History and Hospital Course: 62 yr/o with PMH significant for asthma who was tested positive for COVID-19 almost a week ago although the patient did receive the 2 doses of the vaccine, she was feeling overall okay however for the last 3 days her shortness of breath been getting worse patient did not require any oxygen supplement when she was tested positive neither when she came in yesterday to the ED her chest x-ray was clear however patient on exam clearly has some wheezing. Patient was admitted and started on scheduled bronchodilators along with Solu-Medrol IV due to her recent diagnosis with COVID and increased risk of thrombosis with that D-dimer was checked which was positive and CT of the chest was done however was negative for PE but positive for bibasilar pneumonia consistent with COVID.  This morning patient feeling better, she will be provided with nebulizer machine along with tapered dose of prednisone and antitussives, patient was counseled to continue her isolation at home.
Myalgia, Arthralgia, 12/29 myalgias/arthralgias, soft stool 12/30 fatigue.
Generalized itching. Rash on chest. BENADRYL helped with itching.
8/4/05 - Pt noticed red, painful swelling on back of right arm. Pt experienced vomiting, malaise, diarrhea, headache, lasting thru 8/8/05. Arm redness measured 8-10 inches.
[pfizer covid 19 vaccine] treatment under Emergency Use Authorization(EUA):pfizer covid 19 vaccine administration  12/28/2020 0830 left deltoid. At 1200 (within 4 hrs) began experiencing L sided facial and Left foot numbness/tingling and left hand. At 1600- palpitations, chest tightness.  1900-chills, myalgia, cold sensation of b/l feet. 12/20-+fatigue, SOB, left sided low back pain - severe 12/30-headache, left ear pain, left face pain/continued numbness tingling 12/31-mild facial weakness left forehead, left cheek/smile asymmetry. Reported to health care provider, began steroid for early onset bell's palsy. Today is 1/8/2021 continue to have paresthesia of my left face, left hand, left foot, headache, mild left facial weakness/altered sensation Use Authorization(EUA):